The response of 17-hydroxyprogesterone (17-OHP) and cortisol (F) to a 6-hr ACTH stimulation in families of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency was studied. These studies demonstrated that siblings who should be heterozygous carriers of the 21-hydroxylase deficiency gene based on HLA genotyping are hormonally different from the general population.
Summary
The response of 17-hydroxyprogesterone (17-OHP) and cortisol (F) to a 6-hr ACTH stimulation in families of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency was studied. These studies demonstrated that siblings who should be heterozygous carriers of the 21-hydroxylase deficiency gene based on HLA genotyping are hormonally different from the general population.
In Dre-and earlv ~u b e r t a l children predicted to be heterozygous carriers of the genkbased on HLA gknotyping, the 17-OHP level (13.1 4.5 ng/ml), the rate of increase of 17-OHP (0.03 f 0.01), and the ratio of 17-OHP/F at 6 hr (0.27 + 0.07) were significantly higher ( P < 0.001) than in the control population, (3.9 2 1.9.0.009 + 0.005, and 0.08 + 0.04 ng/ml, respectively). In late and postpubertal males, these hormonal parameters in the heterozygotes (17 a 9.7, 0.04 a 0.026, 0.42 a 0.33 ng/ml, respectively) were significantly higher ( P < 0.001) than in the general population (5.3 + 1.6, 0.009 f 0.004, and 0.1 + 0.03 ng/ml, respectively).
In postmenarchal females, the mean hormone responses in the heterozygotes (12.1 + 9.7, 0.03 + 0.02, and 0.27 + 0.24 ng/ml, respectively) were significantly higher ( P < 0.005, < 0.01, < 0.005, respectively) than in the general population (5.2 + 2.5, 0.01 + 0.007, and 0.1 + 0.04 ng/ml, respectively). However, the overlap ping values did not permit a clear differentiation of the hormonal responses in these two groups.
Another (ACTH) stimulation in one family demonstrated that a father of a patient probably is a previously unrecognized homozygous affected patient and, thus, revision of the congenital adrenal hyperplasia (CAH) genotype for this family was required.
Speculation
In families of patients with CAH due to 21-hydroxylase deficiency, siblings predicted to be heterozygous carriers of the gene for 21 hydroxylase deficiency based on HLA genotyping, will express z mild enzyme deficiency by hormonal testing.
CAH due to 21-hydroxylase deficiency (21-OH-def.) is an inborn error of metabolism transmitted by an autosomal recessive gene (3) . Previous studies have demonstrated hormonal evidence of a mild 21-OH-def. in parents of children with CAH who are obligate heterozygotes (2-4,7-10, 12, 13, 17, 18). However, similar studies in siblings (sibs) of patients with CAH have been difficult to interpret because of the inability to ascertain which sib was a heterozygous carrier of the gene and which sib was genetically unaffected (2, 8, 9, 13, 17, 18) .
Recently, it has been shown that there is close genetic linkage between the HLA complex and CAH (5, 14, 16, 20) . These reports suggested that HLA-genotyping may be used for the detection of heterozygosity of sibs of patients with CAH.
The present study was undertaken to examine whether sibs who should be heterozygous carriers of the 21-OH-def. gene based on HLA-genotyping also express hormonal differences during ACTH stimulation from the general population and from the sibs who are homozygous normal according to HLA typing.
MATERIALS A N D METHODS

SUBJECTS
Families of CA H (21 OH-Dt$) H LA-genot y ping and hormonal response to ACTH stimulation were determined in nine families with one or more children with CAH. A total of 38 clinically normal family members were studied. There were eight mothers, eight postmenarchal and three pre-menarchal sisters. There were six fathers, nine postpubertal and four prepubertal brothers.
By HLA-genotyping, all sisters were heterozygous whereas two of the nine brothers were homozygous unaffected. The remainder were heterozygotes. The hormonal responses of these family members are illustrated in Figures 1-3 . In addition, one father and one postpubertal brother who were undiagnosed CAH patients and two known prepubertal untreated male patients with CAH were studied. The data of these patients appear in Table 1 .
HLA-Typing and Assignment of CA H Genotyping. HLA-typing was performed on peripheral blood lymphocytes usicg the standard two stage NIH microcytotoxicity test. The assignment of heterozygosity for the gene for CAH was based on the presence of one HLA haplotype in common with the affected sib. The parents were assumed to be obligate heterozygotes for CAH. Unaffected homozygous sibs shared no haplotypes with the affected CAH sib. Based on these assumptions, HLA genotyping revealed two unaffected homozygous brothers, one unaffected homozygous sister, 22 heterozygous sisters and brothers, and one previously undiagnosed affected brother.
General Population. Eight postpubertal males (two hospitalized normals, four normal volunteers, and two postpubertal male sibs who were homozygous unaffected for CAH according to the HLA genotype) served as the control postpubertal male general population. Four hospitalized postmenarchal females and nine postmenarchal female volunteers represented the post-menarchal female control population. The hospitalized normals underwent ACTH stimulation tests as part of an endocrine evaluation and were proven to have normal adrenal function.
All subjects were studied in the Pediatric Clinical Research Center at The New York Hospital-Come11 Medical Center after informed consent from either the study subjects or their parents was obtained.
Hormonal Gen. pop. Het. Gen pop. Het n = 2 9 n = 7 n = 2 9 n = 7 n Z 2 7 n = 7
Meant SD 3.9 + 1. were measured before and after ACTH (40 units of Acthar) was Wilcoxon nonparametric rank test was used for statistical analadministered iv for 6 hr. Serum 17-OHP was determined by ysis. radioimmunoassay as previously described (15) and serum F was measured by using a modified radioimmunoassay after celite RESULTS chromatography (1). The inter-and intra-assay variability were less than 15% for both radioimmunoassay of 17-OHP and F. ' Previously undiagnosed brother affected with CAH according to HLA genotyping and hormonal studies.
Dexamethasone, 2 mg/d for 5 days.
BASELINE VALUES OF 17-OHP
CAH GENOTYPES
Prepubertal and early pubertal heterozygote children showed a Pre-hormonal studies Post-hormonal studies significantly higher baseline level of 17-OHP (P < 0.01) than the age and pubertal stage matched children from the general population (heterozygotes 1.47 f 0.9, general population 0.6 f 0.4 ng/ ml, mean f I SD). However, there was some overlap between the heterozygous and the general population. The baseline 17-OHP level in late and postpubertal males (mean f SD: 1.7 * 1.0 ng/ ml) and females (mean + SD: 1.3 k 0.9 ng/ml) from the general population did not differ significantly from that of the heterozygotes (males: 2.0 f 0.9 ng/ml; females 2.0 f 2.3 ng/ml.
;yz 4 4 STIMULATED 17-OHP VALUES
The heterozygous prepubertal children showed a significantly higher ACTH stimulated level of 17-OHP, 17-OHP/F and rate of hormonal studies which revealed the father to be a patient with CAH, increase of 17-OHP compared to the prepubertal general popula-a,b,c, and d represent HLA haplotypes; a' and c' represent the HLA tion (P < 0.001) (Fig. I) . However, there were one or two overlap-haplotypes lined with gene for CAH in the affected child (f). Hormonal ping values between the heterozygotes and general population for studies revealed the father to be affected and, thus, the b haplotype was each parameter.
also linked with the gene for CAH. This resulted in reassignment of the There was also a significant difference in the ACTH stimulated sister as a heterozygote (b0/d).
level of 17-OHP, rate of increase of 17-OHP, and 17-OHP/F in the late pubertal and postpubertal heterozygote males compared to the general population ( P < 0.001) (Fig. 2) .
Neither the rate of increase nor the ratio of 17-OHP/F showed overlapping values between heterozygous sibs and the unaffected sibs or general population in the late and postpubertal males.
Although there was a statistically significant difference in the ACTH stimulated 17-OHP levels, rate of increase of 17-OHP, and ratio of 17-OHP/F between the postmenarchal heterozygous females and the general population ( P < 0.005, < 0.01, < 0.005, respectively), there was considerable overlap in the values of the two groups (Fig. 3) . All postmenarchal females were in the follicular phase of the menstrual cycle with the exception of one female in each group whose cycle was in the luteal phase.
The hormonal profile of a patient's father assumed to be heterozygous for CAH is shown in Table 1 . The baseline 17-OHP level was 3-fold greater than the highest value of 17-OHP seen in the general and the heterozygous population. After ACTH stimulation, the rate of increase of 17-OHP and the ratio of 17-OHP/ F were 5-to 7-fold greater than those of the general and heterozygous population, and 1.5-to 2.2-fold less than the response seen in the untreated patients with CAH after ACTH stimulation. The high baseline 17-OHP level (I0 ng/ml) was suppressed to normal (1.5 ng/ml) after dexamethasone administration (2 mg/day for 5 days).
The HLA-genotypes and the assignment of 21-OH-def. genotypes for this family before and after hormonal studies are given in Figure 4 . Both parents of the affected child with CAH were assumed to be heterozygous and the sister who did not share in HLA haplotype with the affected brother was considered to be homozygous normal before hormonal studies. This sister, however, had a hormonal response clearly consistent with the heterozygous state (Fig. I) . Further, the father demonstrated a hormonal response similar to other homozygous affected males. Therefore, the father was reassigned as a homozygous affected patient and the sister was reassigned to the heterozygous group (Figs. I and 4) . Thus, the genotyping for CAH was revised based on the hormonal data.
One postpubertal male sib who was considered to be normal was found to be HLA identical with his three affected sisters. Hormonal studies confirmed that he was affected with CAH (Table 1) .
DISCUSSION
separation between the heterozygote and control adult female response. If the hormonal response of a postpubertal female sib of a patient with CAH is in the overlapping range, HLA typing may be the only method of ascertaining heterozygosity.
The assignment of CAH genotype based on HLA genotyping assumes that the parent is heterozygous. Should a parent be an undetected patient with CAH, HLA genotyping will be misleading for the assignment of the CAH genotype. This is exemplified in the family illustrated in Figure 4 .
HLA genotyping is valuable in screening family members of patients with CAH to observe the transmission of the gene. These studies revealed a previously undiagnosed sib with CAH who was HLA identical with three sibs affected with CAH. Hormonal studies confirmed the diagnosis of 21-OH-def. in this patient (Table I ). This is the second report in which HLA genotyping disclosed a previously undiagnosed patient (16).
In conclusion, hormonal studies in pre-and early pubertal male and female siblings and postpubertal male siblings have corroborated the assignment of CAH genotype based on HLA genotyping. However, in postmenarchal female sibs, hormonal studies did not clearly distinguish between the heterozygous and general population. Thus, HLA genotyping was a better method for the detection of heterozygosity for CAH, 21-OH def., in the postpubertal females.
